Uses: Ursodeoxycholic Acid Tablets is used in patients with primary biliary cholangitis. Primary biliary cholangitis is a disease in which liver tissue is damaged by an impaired drainage of the bile.
Ursodeoxycholic Acid Tablets belong to a group of medicines called the biliary agents or gallstone dissolution agents used to treat gallstones, primary biliary cholangitis (an autoimmune disease of the liver), excess cholesterol in bile and children above 6 years with biliary and liver diseases caused by cystic fibrosis. Ursodeoxycholic Acid contains ursodeoxycholic acid, which is a naturally occurring bile acid.
Ursodeoxycholic Acid Tablets help decrease the production of cholesterol in the blood, thereby dissolving gall bladder stones composed mainly of cholesterol.
Ursodeoxycholic Acid enhances liver function and protects liver cells from damage brought on by harmful bile acids.
Treatment of Chronic Cholestatic Liver illnesses: The approved medication for treating chronic cholestatic liver illnesses is ursodeoxycholic acid. Its effects include cytoprotection, immunomodulation, membrane stabilization, anti-oxidation, and anti-apoptotic properties. It is frequently used to treat a variety of pediatric cholestatic liver diseases, chronic graft versus host disease, intrahepatic cholestasis of pregnancy, primary biliary cirrhosis (PBC), primary sclerosing cholangitis, liver disease associated with cystic fibrosis, and total parenteral nutrition-associated cholestasis.
Breaking Down Cholesterol Gallstones: Ursodeoxycholic acid affects the bile’s makeup and can aid in the breakdown of cholesterol gallstones. It lowers the quantity of cholesterol in bile and aids in blood cholesterol regulation.
Protective Effect on Liver Cells: Research has stated that ursodeoxycholic acid offers protection for liver cells. In individuals with primary biliary cirrhosis, it can assist in improving liver function and postpone the need for liver transplantation.
Possible Prevention of Disease Progression: Patients with primary biliary cirrhosis (PBC) have been shown to live longer and experience a delay in the onset of their illness when they get prolonged ursodeoxycholic acid therapy. There is evidence to suggest that it may even stop PBC’s histologic stage from progressing.
Each uncoated tablet conatins:-Ursodeoxycholic Acid 300mg